Literature DB >> 9539074

A normal platelet count at admission in acute meningococcal disease does not exclude a fulminant course.

M Van Deuren1, C Neeleman, L G Van 't Hek, J W Van der Meer.   

Abstract

OBJECTIVE: To determine the value of the platelet count at admission for the assessment of the severity of disease in acute meningococcal infections.
DESIGN: Retrospective and prospective, descriptive patient study.
SETTING: University Hospital Intensive Care Unit (ICU). PATIENTS: All patients (n = 92) with acute meningococcal disease from 1985 to 1997, who arrived at the ICU within 12 h after hospital admission and had more than one platelet count during the first 12 h. MEASUREMENTS AND
RESULTS: After admission, platelets dropped in 95% of the patients. At admission, 2/41 (5%) of the non-hypotensive patients and 13/51 (25%) of the hypotensive patients had platelets fewer than 100 x 10(9)/l. During the following 12 h, these percentages increased to 15% and 71%, respectively. Fatalities had, at admission, a median platelet count of 111 x 10(9)/l (range, 19-302 x 10(9)/l), whereas the nadir, occurring at median 7.0 h (range, 1.3-12 h), was 31 x 10(9)/l (range, 12-67 x 10(9)/l). Plasma TNF, measured shortly after admission, correlated better with the platelet nadir (r = -0.65, p < 0.0001) than with the platelet count at admission. Similarly, serum lactate correlated better with the platelet nadir.
CONCLUSIONS: As platelets drop after admission, the use of the platelet count at admission for the assessment of the prognosis in acute meningococcal disease may be misleading. Frequently repeated platelet counts are a better tool for evaluating the severity of disease.

Entities:  

Mesh:

Year:  1998        PMID: 9539074     DOI: 10.1007/s001340050538

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  39 in total

1.  Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease.

Authors:  P Brandtzaeg; G B Joø; B Brusletto; P Kierulf
Journal:  Thromb Res       Date:  1990-01-15       Impact factor: 3.944

2.  [Not meningitis but septic shock as the killer in acute meningococcal disease].

Authors:  G D Vos; A Wiegman; J A Romijn; A M Meurs; M J Bruins-Stassen; R P Bijlmer; J J van Lieshout
Journal:  Ned Tijdschr Geneeskd       Date:  1989-04-15

3.  Fulminant meningococcemia. Heparin therapy and survival rate.

Authors:  S G Manios; F Kanakoudi; E Maniati
Journal:  Scand J Infect Dis       Date:  1971

4.  Prognostic Factors in meningococcal disease.

Authors:  P M Niklasson; P Lundbergh; T Strandell
Journal:  Scand J Infect Dis       Date:  1971

Review 5.  Disseminated intravascular coagulation: diagnosis and treatment.

Authors:  T Baglin
Journal:  BMJ       Date:  1996-03-16

6.  Meningococcal disease: a comparison of eight severity scores in 125 children.

Authors:  H H Derkx; J van den Hoek; W K Redekop; R P Bijlmer; S J van Deventer; P M Bossuyt
Journal:  Intensive Care Med       Date:  1996-12       Impact factor: 17.440

7.  Coagulopathy as a predictor of outcome in meningococcal sepsis and the systemic inflammatory response syndrome with purpura.

Authors:  M L McManus; K B Churchwell
Journal:  Crit Care Med       Date:  1993-05       Impact factor: 7.598

8.  Relation between cytokines and routine laboratory data in children with septic shock and purpura.

Authors:  J A Hazelzet; E van der Voort; J Lindemans; P G ter Heerdt; H J Neijens
Journal:  Intensive Care Med       Date:  1994-05       Impact factor: 17.440

9.  Case fatality of meningococcal disease in western Norway.

Authors:  A Halstensen; S H Pedersen; B Haneberg; B Bjorvatn; C O Solberg
Journal:  Scand J Infect Dis       Date:  1987

10.  Disseminated intravascular coagulation in patients with meningococcal infection: laboratory diagnosis and prognostic factors.

Authors:  H Vik-Mo; K Lote; A Nordøy
Journal:  Scand J Infect Dis       Date:  1978
View more
  3 in total

Review 1.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  Pre-admission clinical course of meningococcal disease and opportunities for the earlier start of appropriate intervention: a prospective epidemiological study on 752 patients in the Netherlands, 2003-2005.

Authors:  S C de Greeff; H E de Melker; L M Schouls; L Spanjaard; M van Deuren
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-05-21       Impact factor: 3.267

Review 3.  Blood platelets and sepsis pathophysiology: A new therapeutic prospect in critically [corrected] ill patients?

Authors:  Antoine Dewitte; Sébastien Lepreux; Julien Villeneuve; Claire Rigothier; Christian Combe; Alexandre Ouattara; Jean Ripoche
Journal:  Ann Intensive Care       Date:  2017-12-01       Impact factor: 6.925

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.